Sutro Biopharma Inc (STRO)
3.995
-0.16
(-3.73%)
USD |
NASDAQ |
May 17, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Cash from Operations (Quarterly): -64.74M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -64.74M |
| December 31, 2023 | 14.07M |
| September 30, 2023 | -33.50M |
| June 30, 2023 | -31.20M |
| March 31, 2023 | -60.99M |
| December 31, 2022 | -23.86M |
| September 30, 2022 | 65.85M |
| June 30, 2022 | -3.186M |
| March 31, 2022 | -35.26M |
| December 31, 2021 | -21.58M |
| September 30, 2021 | -24.41M |
| June 30, 2021 | -5.263M |
| March 31, 2021 | -30.43M |
| Date | Value |
|---|---|
| December 31, 2020 | -18.88M |
| September 30, 2020 | -17.69M |
| June 30, 2020 | -12.50M |
| March 31, 2020 | -18.73M |
| December 31, 2019 | -13.16M |
| September 30, 2019 | -16.12M |
| June 30, 2019 | -15.60M |
| March 31, 2019 | -20.14M |
| December 31, 2018 | -5.935M |
| September 30, 2018 | 47.57M |
| June 30, 2018 | -13.94M |
| March 31, 2018 | -15.01M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-64.74M
Minimum
Mar 2024
65.85M
Maximum
Sep 2022
-18.36M
Average
-18.81M
Median
Cash from Operations (Quarterly) Benchmarks
| AnaptysBio Inc | -37.25M |
| ABVC BioPharma Inc | -0.4795M |
| Reviva Pharmaceuticals Holdings Inc | -11.73M |
| Flora Growth Corp | -1.131M |
| Journey Medical Corp | -5.019M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 64.10M |
| Cash from Financing (Quarterly) | -3.429M |
| Free Cash Flow | -119.18M |
| Free Cash Flow Per Share (Quarterly) | -1.061 |
| Free Cash Flow to Equity (Quarterly) | -61.13M |
| Free Cash Flow to Firm (Quarterly) | -59.89M |
| Free Cash Flow Yield | -48.85% |